[{"Assets_0_Q1_USD":2086400000.0,"CommonStockSharesOutstanding_0_Q1_shares":46695242.0,"EarningsPerShareBasic_1_Q1_USD":0.27,"EarningsPerShareDiluted_1_Q1_USD":0.27,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":37000000.0,"NetIncomeLoss_1_Q1_USD":12800000.0,"StockholdersEquity_0_Q1_USD":1130900000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":47400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":46700000.0,"Ticker":"AVNS","CIK":"1606498","name":"HALYARD HEALTH, INC.","OfficialName":"Avanos Medical Inc. Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1515595188.0","Country":"United States","Sector":"Health Care","Industry":"Industrial Specialties","Market":"NYSE","SP500":"nan","filed":"20170502"}]